Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 37.0 | 49 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 236.0 | 55 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 228.0 | 51 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 53.5 | 62 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 20.0 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 47.0 | 64 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 48.0 | 47 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 288.0 | 39 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 371.0 | 33 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 39.0 | 36 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 37.0 | 43 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 41.0 | 39 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | b-NGF | 31.5 | 52 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 222.0 | 65 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | b-NGF | 174.0 | 60 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 38.0 | 53 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | b-NGF | 22.0 | 58 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 34.0 | 53 | ||||
RA2159 | 2 | b-NGF | 35.5 | 48 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 286.0 | 63 | ||||
N2645 | 2 | b-NGF | 237.0 | 40 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 29.0 | 35 | ||||
RA2708 | 2 | b-NGF | 24.0 | 51 | |||||||
0 | b-NGF | 17.0 | 29 | ||||||||
0 | b-NGF | 15.0 | 45 |